vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Sinclair, Inc. (SBGI). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $836.0M, roughly 1.1× Sinclair, Inc.). Sinclair, Inc. runs the higher net margin — 13.0% vs 0.7%, a 12.3% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs -16.7%). Sinclair, Inc. produced more free cash flow last quarter ($79.0M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 2.4%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Sinclair, Inc., doing business as Sinclair Broadcast Group, is a publicly traded American telecommunications conglomerate that is controlled by the descendants of company founder Julian Sinclair Smith. Headquartered in the Baltimore suburb of Cockeysville, Maryland, the company is the second-largest television station operator in the United States by number of stations after Nexstar Media Group, owning or operating 193 stations across the country in over 100 markets, covering 40% of American ...
ASTH vs SBGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $836.0M |
| Net Profit | $6.6M | $109.0M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 9.6% |
| Net Margin | 0.7% | 13.0% |
| Revenue YoY | 42.9% | -16.7% |
| Net Profit YoY | 184.4% | -38.1% |
| EPS (diluted) | $0.12 | $1.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $836.0M | ||
| Q3 25 | $956.0M | $773.0M | ||
| Q2 25 | $654.8M | $784.0M | ||
| Q1 25 | $620.4M | $776.0M | ||
| Q4 24 | $665.2M | $1.0B | ||
| Q3 24 | $478.7M | $917.0M | ||
| Q2 24 | $486.3M | $829.0M | ||
| Q1 24 | $404.4M | $798.0M |
| Q4 25 | $6.6M | $109.0M | ||
| Q3 25 | $373.0K | $-1.0M | ||
| Q2 25 | $9.4M | $-64.0M | ||
| Q1 25 | $6.7M | $-156.0M | ||
| Q4 24 | $-7.8M | $176.0M | ||
| Q3 24 | $16.1M | $94.0M | ||
| Q2 24 | $19.2M | $17.0M | ||
| Q1 24 | $14.8M | $23.0M |
| Q4 25 | 1.9% | 9.6% | ||
| Q3 25 | 2.0% | 7.5% | ||
| Q2 25 | 3.1% | 2.7% | ||
| Q1 25 | 3.3% | 1.8% | ||
| Q4 24 | 0.1% | 26.5% | ||
| Q3 24 | 5.9% | 19.5% | ||
| Q2 24 | 6.2% | 7.7% | ||
| Q1 24 | 7.5% | 5.3% |
| Q4 25 | 0.7% | 13.0% | ||
| Q3 25 | 0.0% | -0.1% | ||
| Q2 25 | 1.4% | -8.2% | ||
| Q1 25 | 1.1% | -20.1% | ||
| Q4 24 | -1.2% | 17.5% | ||
| Q3 24 | 3.4% | 10.3% | ||
| Q2 24 | 3.9% | 2.1% | ||
| Q1 24 | 3.7% | 2.9% |
| Q4 25 | $0.12 | $1.62 | ||
| Q3 25 | $0.01 | $-0.02 | ||
| Q2 25 | $0.19 | $-0.91 | ||
| Q1 25 | $0.14 | $-2.30 | ||
| Q4 24 | $-0.14 | $2.64 | ||
| Q3 24 | $0.33 | $1.43 | ||
| Q2 24 | $0.40 | $0.27 | ||
| Q1 24 | $0.31 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $866.0M |
| Total DebtLower is stronger | — | $4.4B |
| Stockholders' EquityBook value | $779.3M | $443.0M |
| Total Assets | $2.2B | $5.9B |
| Debt / EquityLower = less leverage | — | 9.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $866.0M | ||
| Q3 25 | $463.4M | $526.0M | ||
| Q2 25 | $342.1M | $616.0M | ||
| Q1 25 | $260.9M | $631.0M | ||
| Q4 24 | $290.8M | $697.0M | ||
| Q3 24 | $350.3M | $536.0M | ||
| Q2 24 | $327.7M | $378.0M | ||
| Q1 24 | $337.3M | $655.0M |
| Q4 25 | — | $4.4B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.1B | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.1B | ||
| Q1 24 | — | $4.1B |
| Q4 25 | $779.3M | $443.0M | ||
| Q3 25 | $775.5M | $347.0M | ||
| Q2 25 | $765.5M | $361.0M | ||
| Q1 25 | $745.4M | $436.0M | ||
| Q4 24 | $712.7M | $583.0M | ||
| Q3 24 | $704.6M | $415.0M | ||
| Q2 24 | $678.9M | $340.0M | ||
| Q1 24 | $653.5M | $333.0M |
| Q4 25 | $2.2B | $5.9B | ||
| Q3 25 | $2.2B | $5.6B | ||
| Q2 25 | $1.4B | $5.7B | ||
| Q1 25 | $1.3B | $5.8B | ||
| Q4 24 | $1.4B | $5.9B | ||
| Q3 24 | $1.3B | $5.8B | ||
| Q2 24 | $1.3B | $5.7B | ||
| Q1 24 | $1.2B | $6.0B |
| Q4 25 | — | 9.84× | ||
| Q3 25 | — | 11.75× | ||
| Q2 25 | — | 11.30× | ||
| Q1 25 | — | 9.56× | ||
| Q4 24 | — | 7.02× | ||
| Q3 24 | — | 9.86× | ||
| Q2 24 | — | 12.08× | ||
| Q1 24 | — | 12.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $98.0M |
| Free Cash FlowOCF − Capex | $-6.0M | $79.0M |
| FCF MarginFCF / Revenue | -0.6% | 9.4% |
| Capex IntensityCapex / Revenue | 0.3% | 2.3% |
| Cash ConversionOCF / Net Profit | -0.44× | 0.90× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $115.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $98.0M | ||
| Q3 25 | $10.0M | $-36.0M | ||
| Q2 25 | $90.9M | $122.0M | ||
| Q1 25 | $16.6M | $5.0M | ||
| Q4 24 | $-10.9M | $198.0M | ||
| Q3 24 | $34.0M | $210.0M | ||
| Q2 24 | $23.2M | $-306.0M | ||
| Q1 24 | $6.0M | $-4.0M |
| Q4 25 | $-6.0M | $79.0M | ||
| Q3 25 | $7.4M | $-58.0M | ||
| Q2 25 | $89.5M | $105.0M | ||
| Q1 25 | $13.6M | $-11.0M | ||
| Q4 24 | $-13.5M | $175.0M | ||
| Q3 24 | $31.7M | $193.0M | ||
| Q2 24 | $20.4M | $-329.0M | ||
| Q1 24 | $5.6M | $-25.0M |
| Q4 25 | -0.6% | 9.4% | ||
| Q3 25 | 0.8% | -7.5% | ||
| Q2 25 | 13.7% | 13.4% | ||
| Q1 25 | 2.2% | -1.4% | ||
| Q4 24 | -2.0% | 17.4% | ||
| Q3 24 | 6.6% | 21.0% | ||
| Q2 24 | 4.2% | -39.7% | ||
| Q1 24 | 1.4% | -3.1% |
| Q4 25 | 0.3% | 2.3% | ||
| Q3 25 | 0.3% | 2.8% | ||
| Q2 25 | 0.2% | 2.2% | ||
| Q1 25 | 0.5% | 2.1% | ||
| Q4 24 | 0.4% | 2.3% | ||
| Q3 24 | 0.5% | 1.9% | ||
| Q2 24 | 0.6% | 2.8% | ||
| Q1 24 | 0.1% | 2.6% |
| Q4 25 | -0.44× | 0.90× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 1.13× | ||
| Q3 24 | 2.11× | 2.23× | ||
| Q2 24 | 1.21× | -18.00× | ||
| Q1 24 | 0.40× | -0.17× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SBGI
| Distribution Revenue | $384.0M | 46% |
| Core Advertising Revenue | $312.0M | 37% |
| Tennis Segment | $62.0M | 7% |
| Other | $40.0M | 5% |
| Other Media Non Media Revenuesand Intercompany Revenues | $24.0M | 3% |
| Political Advertising Revenue | $14.0M | 2% |
